Literature DB >> 12876410

Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors.

Riccardo Asero1, Alberto Tedeschi, Maurizio Lorini, Gianni Caldironi, Fiorella Barocci.   

Abstract

BACKGROUND: A subset of drug-intolerant patients show a marked propensity to react to several chemically unrelated antibacterial drugs. This condition is termed multiple drug allergy syndrome (MDAS). The pathogenesis of MDAS is still unclear. A possible mechanism is that a nonspecific patient-related factor leading to direct histamine release from mast cells and basophils is involved. We investigated whether a patient-related facilitating factor such as the clinically unapparent presence of circulating histamine-releasing factors may represent a nonspecific mechanism underlying drug-induced histamine release in patients with MDAS.
METHODS: 38 otherwise healthy adults with a history of acute urticaria following the ingestion of antibacterial drugs [18 subjects with MDAS (patients) and 20 monosensitive subjects (drug-allergic controls) on the basis of both clinical history and single-blind peroral challenges with alternative substances] and 20 subjects without a history of drug allergy (normal controls) underwent an autologous serum skin test (ASST). IgE specific for beta-lactams was measured in sera from 25 subjects (11 patients and 14 drug-allergic controls) with a history of amoxicillin intolerance. Sera from 13 patients and 5 drug-allergic controls (all positive on ASST) were used in the in vitro histamine release assay using basophils from 3 normal donors.
RESULTS: 17 of 18 patients (94%) versus 8 of 20 drug-allergic controls (40%) showed an unequivocal wheal-and-flare reaction on ASST (p < 0.05). Skin reactions were generally more intense in the patient group. In one MDAS patient, the ASST was not assessable due to dermographism. No normal control was positive on ASST. Sera from 3 of 13 patients (23%) versus 0 of 6 drug-allergic controls (not significant) induced significant histamine release from basophils of normal donors. IgE specific for beta-lactams was detected in sera from 1 of 11 patients (9%) versus 5 of 14 drug-allergic controls (36%) (not significant).
CONCLUSION: Most patients with MDAS and more than one third of subjects with a history of hypersensitivity to a single antibacterial drug were characterized by the presence of circulating histamine-releasing factors. Such factors might play a role in drug-induced adverse reactions observed in these patients. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12876410     DOI: 10.1159/000071486

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  8 in total

1.  Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression.

Authors:  K G Blumenthal; Y Li; W W Acker; Y Chang; A Banerji; S Ghaznavi; C A Camargo; L Zhou
Journal:  Allergy       Date:  2018-10       Impact factor: 13.146

Review 2.  New concepts of hive formation in cholinergic urticaria.

Authors:  Tastuya Horikawa; Atsushi Fukunaga; Chikako Nishigori
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

3.  Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.

Authors:  Ditina Desai; Raphaela Goldbach-Mansky; Joshua D Milner; Ronald L Rabin; Keith Hull; Frank Pucino; Nona Colburn
Journal:  Ann Pharmacother       Date:  2009-05       Impact factor: 3.154

4.  Multiple drug intolerance syndrome: a large-scale retrospective study.

Authors:  Hisham M R B Omer; James Hodson; Sarah K Thomas; Jamie J Coleman
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

Review 5.  Chronic urticaria: a focus on pathogenesis.

Authors:  Riccardo Asero; Alberto Tedeschi; Angelo Valerio Marzano; Massimo Cugno
Journal:  F1000Res       Date:  2017-07-11

Review 6.  Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity.

Authors:  Sapan K Behera; Saibal Das; Kavadichanda G Chengappa; Alphienes S Xavier; Sandhiya Selvarajan
Journal:  Curr Clin Pharmacol       Date:  2019

7.  Rationale for the autologous serum skin test in acute versus chronic urticaria.

Authors:  Serkan Demirkan; Ayşe Baççıoğlu
Journal:  Postepy Dermatol Alergol       Date:  2019-12-30       Impact factor: 1.837

8.  Chronic urticaria and drug hypersensitivity in children.

Authors:  Carlo Mastrorilli; Roberto Bernardini; Lucia Liotti; Fabrizio Franceschini; Giuseppe Crisafulli; Silvia Caimmi; Paolo Bottau; Francesca Mori; Fabio Cardinale; Francesca Saretta; Giovanni Simeone; Marcello Bergamini; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.